Mangoceuticals, Inc. Operating Lease Right-of-Use Assets
Mangoceuticals, Inc. (MGRX) had Operating Lease Right-of-Use Assets of $279.25 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $279.25K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $294.06K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $307.86K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $11.21K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $279.25K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $294.06K 10-Q · filed 2026-05-19 |
| 2025-12-31 | $307.86K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $11.21K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $27.67K 10-Q/A · filed 2025-11-14 |
| 2025-03-31 | $43.77K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $59.49K 10-K · filed 2026-04-01 |
| 2024-09-30 | $74.91K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $90.01K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $104.79K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $119.26K 10-K · filed 2025-03-20 |
| 2023-09-30 | $133.43K 10-Q · filed 2023-10-27 |
| 2023-06-30 | $147.16K 10-Q · filed 2023-07-28 |
| 2023-03-31 | $160.92K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $174.24K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |